advertisement
Advances in Therapy 29
Showing records 1 to 25 | Display all abstracts in Advances in Therapy70004 Systematic Review of Current Devices for 24-h Intraocular Pressure Monitoring
Ittoop SM
Advances in Therapy 2016; 33: 1679-1690
70805 Current Perspectives on the Use of Anti-VEGF Drugs as Adjuvant Therapy in Glaucoma
Andrés-Guerrero V
Advances in Therapy 2017; 34: 378-395
70361 Outcomes Following Implantation of Two Second-Generation Trabecular Micro-Bypass Stents in Patients with Open-Angle Glaucoma on One Medication: 18-Month Follow-Up
Lindstrom R
Advances in Therapy 2016; 33: 2082-2090
70665 24-Hour Efficacy and Ocular Surface Health with Preservative-Free Tafluprost Alone and in Conjunction with Preservative-Free Dorzolamide/Timolol Fixed Combination in Open-Angle Glaucoma Patients Insufficiently Controlled with Preserved Latanoprost Monothe
Konstas AG
Advances in Therapy 2017; 34: 221-235
70004 Systematic Review of Current Devices for 24-h Intraocular Pressure Monitoring
Soohoo JR
Advances in Therapy 2016; 33: 1679-1690
70361 Outcomes Following Implantation of Two Second-Generation Trabecular Micro-Bypass Stents in Patients with Open-Angle Glaucoma on One Medication: 18-Month Follow-Up
Lewis R
Advances in Therapy 2016; 33: 2082-2090
70805 Current Perspectives on the Use of Anti-VEGF Drugs as Adjuvant Therapy in Glaucoma
Perucho-González L
Advances in Therapy 2017; 34: 378-395
70665 24-Hour Efficacy and Ocular Surface Health with Preservative-Free Tafluprost Alone and in Conjunction with Preservative-Free Dorzolamide/Timolol Fixed Combination in Open-Angle Glaucoma Patients Insufficiently Controlled with Preserved Latanoprost Monothe
Boboridis KG; Kapis P
Advances in Therapy 2017; 34: 221-235
70361 Outcomes Following Implantation of Two Second-Generation Trabecular Micro-Bypass Stents in Patients with Open-Angle Glaucoma on One Medication: 18-Month Follow-Up
Hornbeak DM
Advances in Therapy 2016; 33: 2082-2090
70004 Systematic Review of Current Devices for 24-h Intraocular Pressure Monitoring
Seibold LK
Advances in Therapy 2016; 33: 1679-1690
70805 Current Perspectives on the Use of Anti-VEGF Drugs as Adjuvant Therapy in Glaucoma
García-Feijoo J
Advances in Therapy 2017; 34: 378-395
70361 Outcomes Following Implantation of Two Second-Generation Trabecular Micro-Bypass Stents in Patients with Open-Angle Glaucoma on One Medication: 18-Month Follow-Up
Voskanyan L
Advances in Therapy 2016; 33: 2082-2090
70805 Current Perspectives on the Use of Anti-VEGF Drugs as Adjuvant Therapy in Glaucoma
Morales-Fernández L
Advances in Therapy 2017; 34: 378-395
70665 24-Hour Efficacy and Ocular Surface Health with Preservative-Free Tafluprost Alone and in Conjunction with Preservative-Free Dorzolamide/Timolol Fixed Combination in Open-Angle Glaucoma Patients Insufficiently Controlled with Preserved Latanoprost Monothe
Marinopoulos K
Advances in Therapy 2017; 34: 221-235
70004 Systematic Review of Current Devices for 24-h Intraocular Pressure Monitoring
Mansouri K
Advances in Therapy 2016; 33: 1679-1690
70665 24-Hour Efficacy and Ocular Surface Health with Preservative-Free Tafluprost Alone and in Conjunction with Preservative-Free Dorzolamide/Timolol Fixed Combination in Open-Angle Glaucoma Patients Insufficiently Controlled with Preserved Latanoprost Monothe
Voudouragkaki IC
Advances in Therapy 2017; 34: 221-235
70004 Systematic Review of Current Devices for 24-h Intraocular Pressure Monitoring
Kahook MY
Advances in Therapy 2016; 33: 1679-1690
70361 Outcomes Following Implantation of Two Second-Generation Trabecular Micro-Bypass Stents in Patients with Open-Angle Glaucoma on One Medication: 18-Month Follow-Up
Giamporcaro JE
Advances in Therapy 2016; 33: 2082-2090
70805 Current Perspectives on the Use of Anti-VEGF Drugs as Adjuvant Therapy in Glaucoma
Saenz-Francés F
Advances in Therapy 2017; 34: 378-395
70665 24-Hour Efficacy and Ocular Surface Health with Preservative-Free Tafluprost Alone and in Conjunction with Preservative-Free Dorzolamide/Timolol Fixed Combination in Open-Angle Glaucoma Patients Insufficiently Controlled with Preserved Latanoprost Monothe
Panayiotou D
Advances in Therapy 2017; 34: 221-235
70361 Outcomes Following Implantation of Two Second-Generation Trabecular Micro-Bypass Stents in Patients with Open-Angle Glaucoma on One Medication: 18-Month Follow-Up
Hovanesian J
Advances in Therapy 2016; 33: 2082-2090
70805 Current Perspectives on the Use of Anti-VEGF Drugs as Adjuvant Therapy in Glaucoma
Herrero-Vanrell R
Advances in Therapy 2017; 34: 378-395
70361 Outcomes Following Implantation of Two Second-Generation Trabecular Micro-Bypass Stents in Patients with Open-Angle Glaucoma on One Medication: 18-Month Follow-Up
Sarkisian S
Advances in Therapy 2016; 33: 2082-2090
70805 Current Perspectives on the Use of Anti-VEGF Drugs as Adjuvant Therapy in Glaucoma
Júlvez LP
Advances in Therapy 2017; 34: 378-395
70665 24-Hour Efficacy and Ocular Surface Health with Preservative-Free Tafluprost Alone and in Conjunction with Preservative-Free Dorzolamide/Timolol Fixed Combination in Open-Angle Glaucoma Patients Insufficiently Controlled with Preserved Latanoprost Monothe
Mikropoulos DG; Pagkalidou E
Advances in Therapy 2017; 34: 221-235
